New Zealand markets close in 6 hours 7 minutes

Biogen Inc. (BIIB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
197.78-2.84 (-1.42%)
At close: 04:00PM EDT
198.63 +0.85 (+0.43%)
After hours: 07:58PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 28.70B
Enterprise value 31.45B
Trailing P/E 14.14
Forward P/E 12.29
PEG ratio (5-yr expected) 14.81
Price/sales (ttm)2.74
Price/book (mrq)2.42
Enterprise value/revenue 2.96
Enterprise value/EBITDA 10.07

Trading information

Stock price history

Beta (5Y monthly) 0.42
52-week change 3-31.00%
S&P500 52-week change 3-16.88%
52-week high 3291.54
52-week low 3187.16
50-day moving average 3209.11
200-day moving average 3212.86

Share statistics

Avg vol (3-month) 3906.21k
Avg vol (10-day) 31.08M
Shares outstanding 5145.11M
Implied shares outstanding 6N/A
Float 8144.67M
% held by insiders 10.69%
% held by institutions 186.46%
Shares short (30 Aug 2022) 41.89M
Short ratio (30 Aug 2022) 42.53
Short % of float (30 Aug 2022) 41.47%
Short % of shares outstanding (30 Aug 2022) 41.30%
Shares short (prior month 28 Jul 2022) 41.94M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 23:1
Last split date 317 Jan 2001

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022

Profitability

Profit margin 19.36%
Operating margin (ttm)27.78%

Management effectiveness

Return on assets (ttm)7.45%
Return on equity (ttm)13.65%

Income statement

Revenue (ttm)10.63B
Revenue per share (ttm)72.36
Quarterly revenue growth (yoy)-6.70%
Gross profit (ttm)8.87B
EBITDA 3.5B
Net income avi to common (ttm)2.06B
Diluted EPS (ttm)13.79
Quarterly earnings growth (yoy)135.90%

Balance sheet

Total cash (mrq)4.8B
Total cash per share (mrq)33.06
Total debt (mrq)7.55B
Total debt/equity (mrq)63.65
Current ratio (mrq)1.94
Book value per share (mrq)81.77

Cash flow statement

Operating cash flow (ttm)2.54B
Levered free cash flow (ttm)2.1B